ArticleDrugs in context2016

Relative bioavailability of three formulations of galunisertib administered as monotherapy in patients with advanced or metastatic cancer.

Ivelina Gueorguieva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.